FDA Letters Slam Four Compounders Over Sterility, Prescription Issues
Four compounders recently received FDA warning letters that faulted them over sterility concerns and other issues.
Source: Drug GMP Report
Four compounders recently received FDA warning letters that faulted them over sterility concerns and other issues.
Source: Drug GMP Report